Startup Funding rounds – November 14, 2026
Startups worldwide announced 21 rounds of $5M or more between 10:21 IST on Thursday 12 November and 10:21 IST on Sunday 15 November 2026, raising about $3.23B in disclosed capital. Six rounds of $100M or more account for roughly $2.89B of that total.
AI dominated by deal count: 10 of the 21 rounds went to AI companies. Most of that money is buying tools, compute and data plumbing for agents rather than new foundation models. Defence, quantum and industrial robotics produced three of the four largest cheques. A cluster of mid-size fintech and oncology rounds filled out the week.
Non-USD amounts are converted at approximate rates and marked with "~". Every deal was checked against its announcement date; rounds announced on 11 November or earlier are excluded even where outlets reported them later.
AI: 10 rounds, about $1.47B
AI took the most deals and the single largest round. The money is flowing to agent infrastructure: research agents, agent tooling, specialised compute and data context.
Mirendil — $1B Series A (San Francisco)
Mirendil builds AI that does an AI researcher's job: designing experiments, tuning settings, evaluating models and running training. It sells this as a platform, so a team without ML staff, such as a university biology lab, can build its own models. CEO Behnam Neyshabur calls the goal "AI for AI for science."
Kleiner Perkins and Clearlake Capital co-led. Battery Ventures, Doerr Capital, Gil & Co, Google, M13, Pear VC and S32 also invested. Funds go to its Mirendil-Base model, the successor model Fern, and Lor, a system that lets agents run experiments, write code and provision infrastructure.
Neyshabur co-led Gemini reasoning research at Google before joining Anthropic in late 2024 with co-founder Harsh Mehta, who built the first version of Anthropic's internal AI-research platform. Both left in December 2025. The company raised a $200M seed at a $1B valuation in June 2026, co-led by a16z and Kleiner Perkins with Nvidia. No Series A valuation was disclosed.
LangChain — $300M Series C (San Francisco)
LangChain makes the open-source framework and the LangSmith platform that companies use to build, test, monitor and govern AI agents. CapitalG, an existing investor, led the round at a $3B valuation. The company is pitching itself as a neutral home for enterprise agents.
Mount Thor — $45M seed + Series A (San Francisco)
Mount Thor rents out Apple-silicon Macs in the cloud for AI agent training, software testing and inference on open-source models tuned for Apple chips. CRV and Conviction co-led the Series A; Chad Byers and Offline Ventures co-led the seed. Founder and CEO Peter Voell started the company in 2026. Funds go to data-centre capacity, hiring and agent-training infrastructure.
Luminal — $25M Series A (San Francisco)
Luminal, a Y Combinator company, builds a compiler and inference cloud that runs AI models efficiently across GPUs and custom chips. Standard Capital led. One outlet reported the round as $23M; Axios and the lead investor report $25M.
Hatz AI — $24M Series A (New York)
Hatz AI gives IT service providers and smaller businesses a platform to build and run AI tools while keeping control of data, security and spend. Nadia Partners led, with Vestigo Ventures and The Private Shares Fund.
Nebuly — $21M Series A (Europe)
Nebuly shows companies the financial return from their AI agents, covering both internal employee tools and customer-facing assistants. Planven led.
Biomatter — $18M Series A (Vilnius, Lithuania)
Biomatter uses AI to design custom enzymes for pharmaceutical and industrial production. Astanor and UVC Partners backed the round. It is building an enzyme lab in Vilnius and pushing into the US.
Qingkui Zhizao (青葵智造) — ~$14M Series A (Beijing)
Qingkui Zhizao builds self-driving labs and is developing a cloud lab service for pharma, energy, chemicals, materials and university research. The round was about RMB 100M. No lead was named; Chuangdongfang Investment was listed first, alongside Feirongda and Jinhui Big Data.
Tristar AI — $12.4M Series A (Cambridge, Massachusetts)
Tristar AI runs real-time visual inspection that catches factory defects as products move down the line. Isogon Ventures led.
Delphina — $7.5M (San Francisco)
Delphina's Context Factory uses AI agents to build and maintain a company's business context from its data and documents, so data teams and executives work from figures they trust. Radical Ventures and Costanoa co-led, joined by Fei-Fei Li and Nobel economist Guido Imbens. Founders are Jeremy Hermann and Duncan Gilchrist. Total funding is now $15M.
Defence, quantum and space: 3 rounds, about $1.01B
Deep tech outside AI produced the week's second- and fifth-largest rounds, both in strategic sectors with government money in the cap table or the customer base.
UFORCE — $700M Series A at a $6B valuation (London / Kyiv / Washington DC)
UFORCE makes uncrewed systems for sea, land and air plus the command-and-control software that runs them. Its product families are MAGURA sea drones, NEMESIS strike drones, LIUT ground robots and PREDATOR anti-drone turrets.
Valor Equity Partners and the UK National Wealth Fund co-led. New investors include the US–Ukraine Reconstruction Investment Fund, Menlo Ventures, Xantium and Hiro Capital; Shield Capital, Ballistic Ventures, Lakestar and Squadra added to their stakes. Gen. (Ret.) Christopher Cavoli, former NATO Supreme Allied Commander Europe and now a Valor partner, joins the board. Oleg Rogynskyy is CEO.
Tech.eu credits MAGURA with destroying more than a dozen Russian warships in the Black Sea. NEMESIS drones have flown over 300,000 combat sorties across 100+ units. No revenue was disclosed. Funds go to scaling production for Ukraine and spreading manufacturing across the US, Europe, Asia-Pacific and the Middle East, including UK jobs tied to the National Wealth Fund's stake.
Q-CTRL — $290M Series C (Sydney)
Q-CTRL makes software that controls and stabilises quantum hardware, and is building quantum navigation that works without GPS. Salesforce Ventures led the round, which is about A$415M in local currency. Coverage describes the company as Australia's first quantum unicorn.
Gama — ~$17M seed (Ivry-sur-Seine, France)
Gama makes lightweight folding solar power systems for satellites, aimed at their growing power demands. The €15M round had no named lead; Transition, Planet A, Draper Associates and Manta Ray invested. Its first production line is in Ivry-sur-Seine.
Robotics: 1 round, $500M
One late-stage European round carried the category, at a reported $8.5B valuation.
Agile Robots — $500M Series F (Munich, Germany)
Agile Robots makes AI-powered industrial robots, including robotic arms and humanoid systems. SoftBank led, with Nvidia, Hitachi and T Capital participating. Startbase reported the valuation at $8.5B. The company opened a factory near Munich earlier in 2026.
Two AI rounds above also sit close to robotics: Tristar AI's factory-line inspection and Qingkui Zhizao's self-driving labs.
Fintech: 3 rounds, $144M
Fintech money went to infrastructure — market data, banking rails and payment rails — across three continents.
Databento — $100M Series C at a $1.1B valuation (Salt Lake City)
Databento sells financial market data through standardised APIs, positioning itself as a cheaper, developer-friendly alternative to terminal incumbents. Fifth Down Capital led. The round comes four months after a $97M Series B led by NEA in July 2026.
Nova — $24M Series A (Brazil)
Nova lets consumers pay Pix bills such as rent and tuition with their existing credit card limit. Canaan led.
Griffin — $20M Series B (London)
Griffin is a fully licensed UK bank that offers banking-as-a-service, so fintechs can provide accounts and payments without their own licence. Octagon Partners led. The round takes total funding to about $95M, and Griffin is expanding into cards and stablecoins.
Health: 2 rounds, about $74M
Both health rounds target oncology: one a Chinese drug developer, one a French AI platform that predicts which cancer drugs will work.
Phrontline Biopharma (拓济医药) — ~$40M Series A (Hangzhou, China)
Phrontline develops next-generation antibody-drug conjugates (ADCs) for cancer. It specialises in bispecific ADCs, which bind two targets, and dual-payload ADCs, which carry two drugs. It says it is the only biotech to have out-licensed deals in both categories.
TJ101 (EGFR×B7-H3 bispecific ADC) presented Phase Ia data at ESMO 2026.
TJ102 (FRα×CDH6 bispecific, dual-payload) is in the clinic, which the company says is a first for its class.
Yuanhe Origin and Decheng Capital co-led, with Longpan, Jifeng, Mifang Health Fund, Songqing and C&D Emerging Industries. Dr. Zhaoyuan Chen founded the company in early 2022 and runs an R&D centre in Shanghai. A Pre-A+ round of nearly $60M in November 2025 brings its past-year total to about $100M. Funds go to clinical trials, new IND filings, a new payload platform and international partnerships.
Orakl Oncology — ~$34M Series A (Paris, France)
Orakl combines patient-derived tumour samples with AI to predict how cancer drug candidates will perform before clinical trials. The €30M round was co-led by Norrsken VC and Singular, with InfraVia Growth participating.
Enterprise: 1 round, $30M
Security for AI agents drew the week's one enterprise-software round.
Kindo — $30M growth round (Los Angeles)
Kindo provides governance, access control and security for the autonomous AI agents companies are deploying. Crosspoint Capital and Forgepoint Capital, both security-focused investors, co-led.
Climate: 1 round, $8.1M
One grid-software round qualified; the week's other climate-adjacent deals fell outside the window or below $5M.
BluWave-ai — $8.1M Series A-2 (Ottawa, Canada)
BluWave-ai sells AI software that helps utilities and fleet operators optimise renewable energy, battery storage, dynamic pricing and EV charging. No lead was named; angels and family offices, several from Capital Angels Network, invested, and RBC and BMO provided operating capital. Devashish Paul founded the company in 2017. Funds go to Canadian operations, engineering hires, patents and international sales. The source does not say whether the $8.1M is in USD or CAD.
Worth noting and left out
Two more deals surfaced in the window without a disclosed amount, so they are not counted in the totals.
Kalshi: Bloomberg reported on 12 November that the prediction-market platform is in talks for a new round at a $65B valuation. The amount is undisclosed and the round has not closed.
Qingtianzu (擎天租): the Chinese robot-rental platform closed a strategic round of "several hundred million RMB" on 13 November, with Heda Investment and Mango-affiliated funds participating.
Several large rounds were excluded because they were announced on 11 November or earlier, even though some outlets reported them inside the window:
11 November: Fractile (720M),Torus(500M), Imprint (130M),Rox(100M), Edelbyte (70M),Xilect(RMB500M),Neurosterix(105M), Coreshell (30M)andGreenjoules(~16M).
9–10 November: Onodrim, Delix, WhiteMatter, Charta Health, General Translation and Pliant.
Date not confirmed: 4Minds, Duet, EnVision Endoscopy and Agentcard.
All 21 deals
The table lists every qualifying round, largest first; amounts are in US dollars.
Company | Sector | Round | Amount (USD) | Lead(s) | Location |
AI | Series A | 1B | Kleiner Perkins, Clearlake Capital | San Francisco, US | |
Defence | Series A | 700M | Valor Equity Partners, UK National Wealth Fund | London, UK | |
Robotics | Series F | 500M | SoftBank | Munich, Germany | |
AI | Series C | 300M | CapitalG | San Francisco, US | |
Quantum | Series C | 290M | Salesforce Ventures | Sydney, Australia | |
Fintech | Series C | 100M | Fifth Down Capital | Salt Lake City, US | |
AI | Seed + Series A | 45M | CRV, Conviction | San Francisco, US | |
Health | Series A | ~40M | Yuanhe Origin, Decheng Capital | Hangzhou, China | |
Health | Series A | ~34M | Norrsken VC, Singular | Paris, France | |
Enterprise | Growth | 30M | Crosspoint Capital, Forgepoint Capital | Los Angeles, US | |
AI | Series A | 25M | Standard Capital | San Francisco, US | |
Fintech | Series A | 24M | Canaan | Brazil | |
AI | Series A | 24M | Nadia Partners | New York, US | |
AI | Series A | 21M | Planven | Europe | |
Fintech | Series B | 20M | Octagon Partners | London, UK | |
AI | Series A | 18M | Astanor, UVC Partners | Vilnius, Lithuania | |
Space | Seed | ~17M | None named | Ivry-sur-Seine, France | |
AI | Series A | ~14M | None named | Beijing, China | |
AI | Series A | 12.4M | Isogon Ventures | Cambridge, MA, US | |
Climate | Series A-2 | 8.1M | None named | Ottawa, Canada | |
AI | Undisclosed | 7.5M | Radical V |